Paper41357193
Gut microbiota-derived metabolites in immunomodulation and gastrointestinal cancer immunotherapy.
Luo W and 3 others. Front Immunol, 2025. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Gut microbiota-derived metabolites in immunomodulation and gastrointestinal cancer immunotherapy. Papers, record 41357193. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41357193
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gut microbiota-derived metabolites in immunomodulation and gastrointestinal cancer immunotherapy.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastrointestinal Microbiome | Major topic |
| Immunomodulation | Major topic |
| Immunotherapy | Major topic |
| Gastrointestinal Neoplasms | Major topic |
| Humans | |
| Animals | |
| Bile Acids and Salts | |
| Tryptophan | |
| Tumor Microenvironment | |
| Fatty Acids, Volatile |
Source PubMed
References213
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38428738 | Epithelial regulation of microbiota-immune cell dynamics. | Mucosal Immunol | 2024 | https://conductscience.org/library/papers/38428738 | PubMed |
| 2 | 39052651 | A novel system to culture human intestinal organoids under physiological oxygen content to study microbial-host interaction. | PLoS One | 2024 | https://conductscience.org/library/papers/39052651 | PubMed |
| 3 | 41127087 | Vitamins formed by microorganisms in fermented foods: effects on human vitamin status-a systematic narrative review. | Front Nutr | 2025 | https://conductscience.org/library/papers/41127087 | PubMed |
| 4 | 39093627 | Understanding the kynurenine pathway: A narrative review on its impact across chronic pain conditions. | Mol Pain | 2024 | https://conductscience.org/library/papers/39093627 | PubMed |
| 5 | 40368896 | Macrophage-augmented intestinal organoids model virus-host interactions in enteric viral diseases and facilitate therapeutic development. | Nat Commun | 2025 | https://conductscience.org/library/papers/40368896 | PubMed |
| 6 | 40451282 | Bacteria-metabolite butyrate boosts anti-PD1 efficacy in colorectal cancer patient-derived organoids through activating autologous tumour-infiltrating GNLY +CD8+ T cells. | Gut | 2025 | https://conductscience.org/library/papers/40451282 | PubMed |
| 7 | 33043467 | Butyrate as a bioactive human milk protective component against food allergy. | Allergy | 2021 | https://conductscience.org/library/papers/33043467 | PubMed |
| 8 | 35738801 | Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma. | J Immunother Cancer | 2022 | https://conductscience.org/library/papers/35738801 | PubMed |
| 9 | 40415505 | Multifaceted Role of Microbiota-Derived Indole-3-Acetic Acid in Human Diseases and Its Potential Clinical Application. | FASEB J | 2025 | https://conductscience.org/library/papers/40415505 | PubMed |
| 10 | 29798856 | Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. | Science | 2018 | https://conductscience.org/library/papers/29798856 | PubMed |
| 11 | 40812589 | Microbiome-metabolome generated bile acids gatekeep infliximab efficacy in Crohn's disease by licensing M1 suppression and Treg dominance. | J Adv Res | 2026 | https://conductscience.org/library/papers/40812589 | PubMed |
| 12 | 38197259 | Gut microbiome-derived butyrate inhibits the immunosuppressive factors PD-L1 and IL-10 in tumor-associated macrophages in gastric cancer. | Gut Microbes | 2024 | https://conductscience.org/library/papers/38197259 | PubMed |
| 13 | 40367692 | Bile acids produced by gut microbiota activate TGR5 to promote colorectal liver metastasis progression by inducing MDSCs infiltration in liver. | Int Immunopharmacol | 2025 | https://conductscience.org/library/papers/40367692 | PubMed |
| 14 | 40151642 | Enriched pathways in gut microbiome predict response to immune checkpoint inhibitor treatment across demographic regions and various cancer types. | iScience | 2025 | https://conductscience.org/library/papers/40151642 | PubMed |
| 15 | 40441145 | Microbiota-derived urocanic acid triggered by tyrosine kinase inhibitors potentiates cancer immunotherapy efficacy. | Cell Host Microbe | 2025 | https://conductscience.org/library/papers/40441145 | PubMed |
| 16 | 37915930 | The dietary source of trimethylamine N-oxide and clinical outcomes: an unexpected liaison. | Clin Kidney J | 2023 | https://conductscience.org/library/papers/37915930 | PubMed |
| 17 | 39290857 | Double-side role of short chain fatty acids on host health via the gut-organ axes. | Anim Nutr | 2024 | https://conductscience.org/library/papers/39290857 | PubMed |
| 18 | 39859117 | Sodium Butyrate: A Multifaceted Modulator in Colorectal Cancer Therapy. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/39859117 | PubMed |
| 19 | 37770127 | Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis. | Gut | 2023 | https://conductscience.org/library/papers/37770127 | PubMed |
| 20 | 38664391 | Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/38664391 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42979158 | Closing the adaptive window: immune-metabolic strategies to constrain melanoma therapy resistance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42979158 | PubMed |
| 42903294 | Autophagy as a Proposed Regulatory Interface in the Gut Microbiota-Cardiovascular Axis. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42903294 | PubMed |
| 42889462 | Polysaccharide-mediated modulation of gut microbiota and lysine lactylation: implications for tumor microenvironment remodeling and cancer immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42889462 | PubMed |
| 42889412 | Epigenetic regulation of immune checkpoint signaling by microbial metabolites: mechanisms, therapeutic potential, and future perspectives. | Front Immunol | 2026 | https://conductscience.org/library/papers/42889412 | PubMed |
| 42888465 | Intratumoral microbiota in cancer immunotherapy: metabolic-epigenetic crosstalk and engineered bacterial therapeutics. | Exp Hematol Oncol | 2026 | https://conductscience.org/library/papers/42888465 | PubMed |
| 42884589 | The Gut-Skin Axis in Pediatric Atopic Dermatitis: Nutritional Modulation, Microbiome Interactions, and Emerging Precision Approaches. | Nutrients | 2026 | https://conductscience.org/library/papers/42884589 | PubMed |
| 42865133 | Context-dependent TREM2 signalling in myeloid cells: Molecular mechanisms and immunotherapeutic divergence in neurodegeneration and cancer. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/42865133 | PubMed |
| 42797611 | Insights into Microbiota-Vaccine Crosstalk in Humans: Mechanisms, Modulators, and Translational Horizons. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42797611 | PubMed |
| 42781201 | Gut microbiota-innate immune crosstalk in the initiation and progression of CRC: mechanisms and therapeutic potential. | Front Immunol | 2026 | https://conductscience.org/library/papers/42781201 | PubMed |
| 42755487 | Global trends and emerging frontiers in cancer immunotherapy and gut microbiota-derived metabolites: a bibliometric analysis. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42755487 | PubMed |
| 42751182 | Childhood asthma and the microbiome: from gut-lung axis mechanisms to precision prevention strategies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42751182 | PubMed |
| 42739062 | The Adolescent Microbiome-Gut-Brain Axis: Development, Mechanisms, and Translational Perspectives. | Nutrients | 2026 | https://conductscience.org/library/papers/42739062 | PubMed |
| 42738852 | Signaling Metabolites in the Gut Microbiota-Organ Axes. | Cells | 2026 | https://conductscience.org/library/papers/42738852 | PubMed |
| 42733470 | Hippuric acid contributes to NK-cell activation with dependence on TLR2 in chronic hepatitis B complicated by MASLD. | iScience | 2026 | https://conductscience.org/library/papers/42733470 | PubMed |
| 42729542 | The dual roles of Prevotella in gastrointestinal tumorigenesis: from molecular mechanisms to therapeutic prospects. | Front Oncol | 2026 | https://conductscience.org/library/papers/42729542 | PubMed |
| 42649853 | Gut Microbiome-Driven Strategies to Overcome Immunotherapy Resistance in Microsatellite-Stable Colorectal Cancer. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42649853 | PubMed |
| 42591787 | Prognostic value of gut microbiota-derived metabolites in non-small cell lung cancer: a retrospective cohort study of overall survival. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42591787 | PubMed |
| 42589199 | Associations of Inosine with Gut Microbiota, Metabolic Indicators, and Fluid Homeostasis in Kidney-Related Diarrhea. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589199 | PubMed |
| 42522923 | Regulation of PD-1PD-L1 Immune Checkpoints by Gut Microbiota Metabolites and Their Clinical Translational Research: A Review. | Immun Inflamm Dis | 2026 | https://conductscience.org/library/papers/42522923 | PubMed |
| 42507333 | Microbiome-guided cancer immunotherapy: immune mechanisms, resistance pathways, and translational opportunities for precision oncology. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/42507333 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41357193
GET https://conductscience.org/api/papers/v1/41357193/references?page=2